MigVax is a startup developing Migvax-101, a novel oral subunit COVID-19 vaccine that has demonstrated effectivity in pre-clinical tests as a booster for previously vaccinated persons
Company Details
- Employees
- 10
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.migvax.com/home
- Keywords
- Kiryat Shmona.
Migvax Questions
Migvax's website is https://www.migvax.com/home
Migvax's LinkedIn profile is https://www.linkedin.com/company/migvax
Migvax has
10 employees.
View email and phone details for 10
employees at Migvax.
Migvax's industry is
Pharmaceutical Manufacturing
Migvax's top competitors are
Ganko International Sagl,
Hebe Longevity,
Zigdon Enterprises,
Unicrypt,
Collplant,
Bm Premium Trading L.l.c,
Protalix Biotherapeutics,
Ingenium Ip Israel,
Migal Galilee Research Institute,
Omyguide!.
Migvax's categories are Pharmaceutical Manufacturing
